Solas BioVentures

Founded 2014
Founders David Adair

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 11
Average round size
info
The average size of a deal this fund participated in
$14M
Portfolio companies 7
Rounds per year 1.57
Lead investments 2
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.36
Exits 1
Key employees 4
Stages of investment
Early Stage Venture

Areas of investment

  • Health Care
  • Medical Device
  • Biotechnology
  • Medical
  • Manufacturing
Summary

In 2014 was created Solas BioVentures, which is appeared as VC. The fund was located in North America if to be more exact in United States. The main office of represented VC is situated in the Chattanooga.

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Solas BioVentures, startups are often financed by Delphi Ventures, Alloy Ventures, Tech Square Ventures. The meaningful sponsors for the fund in investment in the same round are Tech Square Ventures, Medtronic, Delphi Ventures. In the next rounds fund is usually obtained by William A. Hawkins III, Tech Square Ventures, Piedmont Capital Partners.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no specific favorite in a number of founders of portfolio startups. Among the most popular fund investment industries, there are Biopharma, Health Care. Among the most popular portfolio startups of the fund, we may highlight Arrivo BioVentures LLC, CardioNXT, AEGEA Medical. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund.

We also calculated 4 valuable employees in our database.

The top activity for fund was in 2016. The real fund results show that this VC is 5 percentage points more often commits exit comparing to other companies. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 investment rounds annually. When the investment is from Solas BioVentures the average startup value is 50-100 millions dollars.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Solas BioVentures:
Typical Co-investors
Solas BioVentures is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Solas BioVentures:

Funds with similar focus

Funds from United States, Chattanooga
Funds with similar focus located in United States, Chattanooga:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Health Catalyst Capital United States, New York
HIX Capital Brazil, Sao Paulo
elf Cosmetics United States, New York
Franchise India Holdings Limited India, New Delhi
Longworth Venture Partners United States, Waltham
VIA Technologies Taiwan, Taipei
United Overseas Bank Russia, Moscow
SODECI Côte d'Ivoire, Lagunes
Sunwoda Electronic China, Shenzhen
WuXi Healthcare Ventures United States, Cambridge
Black Coral Capital United States, Boston
Banque Populaire du Rwanda -
QuaeroQ -
Persol Innovation Fund Japan, Chiyoda
Huidaya Investment Management China, Wuhan
Stirling Square Capital Partners United Kingdom, Kersey
Nour Nouf -
Kearny Bank -
A8 New Media Group Ltd China, Shenzhen
Proioxis Ventures -

Notable deals

CompanyIndustryRoundRound SizeDateInvestorsLocation

InterShunt

Health Care
Medical
Medical Device
n/a
$3M11 Jan 2021 United States, City of Saint Louis

Knopp Biosciences

Biotechnology
Health Care
Health Diagnostics
Medical
1
$14M11 Nov 2020 United States, Pittsburgh

BioStable

Biotechnology
Health Care
Health Diagnostics
Medical Device
1
25 Feb 2020 United States, Austin

AEGEA Medical

Biotechnology
Health Care
Manufacturing
Medical Device
1
$17M12 Nov 2018 United States, Redwood City

AEGEA Medical

Biotechnology
Health Care
Manufacturing
Medical Device
1
$40M02 Jan 2018 United States, Redwood City

CardioNXT

Biotechnology
Health Care
Medical
Medical Device
n/a
$2M01 Jun 2017 United States, Denver

PreTel

Commercial
Health Care
Wearables
1
15 Mar 2017 Canada, Peterborough

Arrivo BioVentures LLC

Biopharma
Biotechnology
Health Care
Medical Device
1
$49M25 May 2016 United States, " United States"}

CardioNXT

Biotechnology
Health Care
Medical
Medical Device
n/a
$1M24 May 2016 United States, Denver
News
Cryosa Announces $21.5M Series B Funding

– Medical device startup Cryosa from Singapore completed its Series B funding round, raising $21.5m.
РThe round was led by life sciences firm Solas BioVentures, with additional funding from Series A investors which include life sciences firm Sant̩ Ventures, global technology and med-tech company HOYA Corporation, and additional investors.
– The funding will be used to continue first-in-human clinical trials.

Francis Medical Raises $55M in Series B Equity Funding

– Francis Medical, a Minneapolis MI-based medical device company, raised $55M in Series B equity funding.
– The round was led by Solas BioVentures with participation from Arboretum Ventures, Coloplast A/S, H2Oey Ventures and Tonkawa.
– The company intends to use the funds to fund for the development of its proprietary prostate cancer treatment through FDA 510(k) approval, which includes a pivotal clinical study (VAPOR 2) for the management of prostate cancer.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Solas BioVentures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: